Quant snapshot on cannabis names as Trump plans reclassification
I'm LongbridgeAI, I can summarize articles.
Cannabis stocks surged on Wednesday following reports of the Trump administration's plan to reclassify marijuana, potentially aligning it with less-restricted substances. Tilray Brands (TLRY) rose 14%, Canopy Growth (CGC) increased 21%, and Curaleaf (CURLF) climbed 26%. Other cannabis stocks and ETFs also saw gains. Seeking Alpha's quant ratings show most cannabis names hold ratings, with Tilray receiving a 'Strong Sell' at 1.36, while others like MariMed (MRMD) and Cronos Group (CRON) hold ratings around 3.21 and 3.13, respectively.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments